FASLG and T-cell non-Hodgkin lymphoma: For example, EVs derived from B and T cell lymphomas have been found to be enriched in major histocompatibility complex (MHC), T-cell receptor (TCR), Apo2 ligand (APO2L), Fas ligand (FasL), and natural-killer group-2 member-D (NKG2D), which had the ability to inhibit NK cell cytotoxicity, to promote T cell apoptosis, and to downregulate antigen (Ag) processing by Ag presenting cells [88,89,90].